Colgate-Palmolive (NYSE:CL) Stock Position Decreased by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC reduced its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 24.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 256,034 shares of the company's stock after selling 82,456 shares during the quarter. Commonwealth Equity Services LLC's holdings in Colgate-Palmolive were worth $23,276,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in CL. FMR LLC lifted its holdings in Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock worth $700,642,000 after buying an additional 2,674,807 shares in the last quarter. AMF Tjanstepension AB lifted its holdings in Colgate-Palmolive by 1,088.8% during the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company's stock worth $233,584,000 after buying an additional 2,353,268 shares in the last quarter. Barclays PLC lifted its holdings in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares in the last quarter. State Street Corp lifted its holdings in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after buying an additional 1,784,411 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $132,405,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have issued reports on CL. StockNews.com lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Friday, March 14th. UBS Group dropped their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research report on Monday, February 3rd. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the company an "overweight" rating in a research report on Friday, March 14th. Finally, Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Hold" and an average target price of $101.72.

Remove Ads

Colgate-Palmolive Price Performance

Shares of NYSE CL traded down $0.15 during midday trading on Thursday, hitting $90.29. The company had a trading volume of 5,540,564 shares, compared to its average volume of 4,200,518. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The firm has a market capitalization of $73.28 billion, a price-to-earnings ratio of 25.65, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The business has a 50-day simple moving average of $89.19 and a two-hundred day simple moving average of $94.41. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the company posted $0.87 EPS. Equities research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.